Role of interleukin 1 in the development of atherosclerosis

Role of interleukin 1 in the development of atherosclerosis

Atherosclerosis is now considered as chronic inflammatory vascular disease connected to «pathological» activation of innate and adaptive immunity, characterized by lipid deposition, leukocyte infiltration and proliferation of vascular smooth muscle cells. Subclinical (low grade) inflammation plays f...

Full description

Bibliographic Details
Main Authors:	E. L. Nasonov, T. V. Popkova
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2019-04-01
Series:	Научно-практическая ревматология
Subjects:	atherosclerosis rheumatoid arthritis gout cytokines interleukin 1 canakinumab colchicine
Online Access:	https://rsp.mediar-press.net/rsp/article/view/2687

Similar Items

ANTI-INFLAMMATORY THERAPY FOR ATHEROSCLEROSIS: CONTRIBUTION TO AND LESSONS OF RHEUMATOLOGY
by: E. L. Nasonov, et al.
Published: (2017-10-01)

EXPERIENCE OF ADMINISTRATION OF CANAKINUMAB, AN INTERLEUKIN 1β INHIBITOR, IN A PATIENT WITH CHRONIC TOPHACACEOUS GOUT
by: Maksim Sergeyevna Eliseev, et al.
Published: (2014-03-01)

Assessment of cardiovascular risk from the use of an interleukin-1 inhibitor in patients with severe tophaceous gout
by: M. S. Eliseev, et al.
Published: (2016-03-01)

Therapy with canakinumab for gout
by: M. S. Eliseev, et al.
Published: (2019-04-01)

Role of interleukin-6 in the development of atherosclerosis in rheumatoid arthritis
by: Elena Vasilyevna Udachkina, et al.
Published: (2013-10-01)

Clinical experience with the interleukin-1β blocker canakinumab in patients with chronic tophaceous gout: abolishment of arthritis and prevention of exacerbations when allopurinol is used
by: M. S. Eliseev, et al.
Published: (2015-06-01)

The role of interleukin 1 in the development of human diseases
by: E. L. Nasonov
Published: (2019-04-01)

Interleukin-1β inhibitors for the management of acute gout flares: a systematic literature review
by: Naomi Schlesinger, et al.
Published: (2023-07-01)

Colchicine: Repositioning an “ancient” medicine in the 21<sup>st</sup> century
by: E. L. Nasonov, et al.
Published: (2024-11-01)

Colchicine: Repositioning an “ancient” medicine in the 21st century
by: E. L. Nasonov, et al.
Published: (2018-06-01)

Role of blood cholesterol transport system disturbances in atherosclerosis development in rheumatoid arthritis
by: T. V. Popkova, et al.
Published: (2007-10-01)

Administration of the Interleukin-1 Inhibitor Canakinumab in Children with Autoinflammatory Diseases and Systemic Juvenile Arthritis: the Report for Case Series
by: S. O. Salugina, et al.
Published: (2016-02-01)

The role of interleukin 17 in the pathogenesis of rheumatoid arthritis. Are there any prospects for the use of IL-17 inhibitors?
by: E. L. Nasonov, et al.
Published: (2023-04-01)

Familial Mediterranean fever (periodic disease): history or a real problem
by: E. S. Fedorov, et al.
Published: (2018-09-01)

Efficacy and safety of canakinumab in systemic juvenile idiopathic arthritis, the first Chinese experience
by: Lingzhi Qiu, et al.
Published: (2024-03-01)

Canakinumab in the treatment of systemic juvenile idiopathic arthritis: a retrospective single center study in China
by: Xiaona Zhu, et al.
Published: (2024-03-01)

Therapy with canakinumab for adult-onset still's disease
by: E. L. Nasonov
Published: (2019-04-01)

INHIBITION OF INTERLEUKIN 6 IN IMMUNE INFLAMMATORY RHEUMATIC DISEASES: ACHIEVEMENTS, PROSPECTS, AND HOPES
by: E. L. Nasonov, et al.
Published: (2018-01-01)

The inflammation process of gout arthritis and its treatment
by: Nita Parisa, et al.
Published: (2023-01-01)

Familial Mediterranean Fever: Current Approaches to Diagnosis and Treatment
by: Mikhail M. Kostik, et al.
Published: (2018-12-01)

Rheumatoid arthritis: prototype of accelerated atherosclerosis
by: V. Bruzzese
Published: (2013-05-01)

The efficacy and safety of sarilumab, fully human monoclonal antibodies against interleukin 6 receptor, in rheumatoid arthritis: new evidence
by: E. L. Nasonov, et al.
Published: (2019-11-01)

ROLE OF INTERLEUKIN 1 IN THE DEVELOPMENT OF HUMAN DISEASES
by: E. L. Nasonov, et al.
Published: (2016-03-01)

Glucagon-like Peptide-1 Levels and Related Parameters in Rheumatoid Arthritis Patients Prone to Atherosclerosis
by: Noorhan K. Shafeeq, et al.
Published: (2017-06-01)

Emerging Role of Interleukin-38 (IL-38) in the Development of Rheumatoid Arthritis
by: Shengxiang Liang, et al.
Published: (2024-02-01)

PAPA and FMF in two siblings: possible amplification of clinical presentation? A case report
by: Maria Cristina Maggio, et al.
Published: (2019-08-01)

Colchicine for gout
by: M. S. Eliseev, et al.
Published: (2021-08-01)

The interleukin 1 inhibitor canakinumab in the treatment of cryopyrin-associated periodic syndromes (CAPS): clinical experience
by: Svetlana Olegovna Salugina, et al.
Published: (2014-12-01)

New areas of the pharmacotherapy of rheumatic diseases are inhibition of interleukin-6 and interleukin-17
by: Evgeny Lvovich Nasonov
Published: (2013-10-01)

The use of an interleukin 1 inhibitor in a patient with atypical course of periodic fever
by: M. S. Eliseev, et al.
Published: (2021-06-01)

A snapshot on the on-label and off-label use of the interleukin-1 inhibitors in Italy among rheumatologists and pediatric rheumatologists: a nationwide multi-center retrospective observational study
by: Antonio Vitale, et al.
Published: (2016-10-01)

Experience with canakinumab in a patient with gout and IgA nephropathy
by: E. V. Ilyinykh, et al.
Published: (2019-09-01)

A clinical case of adult-onset Still's disease resistant to therapy with tumor necrosis factor-alpha inhibitors and interleukin-6 inhibitors
by: R. R. Samigullina, et al.
Published: (2019-03-01)

PROSPECTS FOR USING COLCHICINE IN MEDICINE: NEW EVIDENCE
by: Z. S. Alekberova, et al.
Published: (2020-04-01)

Adult Still's disease: New horizons
by: E. L. Nasonov, et al.
Published: (2021-12-01)

Canakinumab in colchicine resistant familial Mediterranean fever and other pediatric rheumatic diseases
by: Mustafa Çakan, et al.
Published: (2020-04-01)

PREDICTION OF MULTIFOCAL ATHEROSCLEROSIS IN WOMEN WITH RHEUMATOID ARTHRITIS
by: I. V. Osipova, et al.
Published: (2018-06-01)

Hypogonadism syndrome in men with inflammatory joint diseases: A review
by: Taras S. Panevin, et al.
Published: (2023-07-01)

Hyperphosphatemic Familial Tumoral Calcinosis With Galnt3 Mutation: Transient Response to Anti‐Interleukin‐1 Treatments
by: Astrid Dauchez, et al.
Published: (2019-07-01)

FAMILIAL MEDITERRANEAN FEVER: ASSESSING THE OVERALL CLINICAL IMPACT AND FORMULATING TREATMENT PLANS
by: Donato Rigante, et al.
Published: (2019-04-01)